Canary Wharf Group and Kadans Science Partner, the AXA-IM-Alts-owned life sciences real estate group, have gained consent from Tower Hamlets council for Europe's largest life sciences building, a 23-storey tower, in London's Docklands.
Canary Wharf Group and Kadans Science Partner, the AXA-IM-Alts-owned life sciences real estate group, have gained consent from Tower Hamlets council for Europe's largest life sciences building, a 23-storey tower, in London's Docklands.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
Real Estate
Real Estate